Skechers U S A, Inc (SKX) concluded trading on Thursday at a closing price of $64.30, with 3.47 million shares of worth about $223.1 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.08% during that period and on February 13, 2025 the price saw a gain of about 2.23%. Currently the company’s common shares owned by public are about 150.97M shares, out of which, 128.90M shares are available for trading.
Stock saw a price change of -14.97% in past 5 days and over the past one month there was a price change of -9.82%. Year-to-date (YTD), SKX shares are showing a performance of -4.37% which increased to 8.36% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $55.67 but also hit the highest price of $78.85 during that period. The average intraday trading volume for Skechers U S A, Inc shares is 2.13 million. The stock is currently trading -10.63% below its 20-day simple moving average (SMA20), while that difference is down -8.38% for SMA50 and it goes to -4.19% lower than SMA200.
Skechers U S A, Inc (NYSE: SKX) currently have 150.97M outstanding shares and institutions hold larger chunk of about 78.89% of that.
The stock has a current market capitalization of $9.71B and its 3Y-monthly beta is at 1.20. PE ratio of stock for trailing 12 months is 15.50, while it has posted earnings per share of $4.15 in the same period. Its PEG reads 1.29 and has Quick Ratio of 1.12 while making debt-to-equity ratio of 0.45. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SKX, volatility over the week remained 5.71% while standing at 3.44% over the month.
Stock’s fiscal year EPS is expected to rise by 2.96% while it is estimated to increase by 15.96% in next year. EPS is likely to shrink at an annualized rate of 12.03% for next 5-years, compared to annual growth of 13.10% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on December 10, 2024 offering a Neutral rating for the stock and assigned a target price of $65 to it. On July 23, 2024, Morgan Stanley Upgrade their recommendations, while on June 07, 2024, BofA Securities Upgrade their ratings for the stock with a price target of $87. Stock get an Overweight rating from Barclays on April 01, 2024.
